Brind.

Entities / Company

Stealth BioTherapeutics (United States).

company in Newton, United States

Seen in 2 reportsLast reported May 20

Reports this week: 0
Active events: 0
Connections: 4

What's happening

Gone quiet

No new reports in 90+ days

The FDA accepted a revised approval submission regarding a Biohaven drug, while simultaneously canceling advisory committee discussions. This occurred amidst corporate restructuring, including Novo Holdings acquiring Catalent, which has a gene therapy facility in Baltimore.

Some support1 report

History

Events by the month they began

June 2026

1 event

Jun 7, 2026The FDA accepted a revised approval submission regarding a Biohaven drug, while simultaneously canceling advisory committee discussions. This occurred amidst corporate restructuring, including Novo Holdings acquiring Catalent, which has a gene therapy facility in Baltimore.